WO2006062750A1 - Systeme a interface d'echantillonnage optique pour mesures de tissus in vivo - Google Patents

Systeme a interface d'echantillonnage optique pour mesures de tissus in vivo Download PDF

Info

Publication number
WO2006062750A1
WO2006062750A1 PCT/US2005/042738 US2005042738W WO2006062750A1 WO 2006062750 A1 WO2006062750 A1 WO 2006062750A1 US 2005042738 W US2005042738 W US 2005042738W WO 2006062750 A1 WO2006062750 A1 WO 2006062750A1
Authority
WO
WIPO (PCT)
Prior art keywords
sample
guide
tissue
probe
alignment piece
Prior art date
Application number
PCT/US2005/042738
Other languages
English (en)
Other versions
WO2006062750B1 (fr
Inventor
Thomas Blank
George Acosta
Mutua Mattu
Marcy Makarewicz
Stephen L. Monfre
Alexander D. Lorenz
Timothy L. Ruchti
Kevin H. Hazen
Donovan D. Berry
Roxanne E. Abul-Haj
Original Assignee
Sensys Medical, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/563,782 external-priority patent/US6415167B1/en
Priority claimed from US10/170,921 external-priority patent/US7206623B2/en
Priority claimed from US10/472,856 external-priority patent/US7133710B2/en
Priority claimed from US11/008,001 external-priority patent/US7606608B2/en
Application filed by Sensys Medical, Inc. filed Critical Sensys Medical, Inc.
Priority to EP05825413A priority Critical patent/EP1824378A4/fr
Priority to JP2007545509A priority patent/JP2008522726A/ja
Publication of WO2006062750A1 publication Critical patent/WO2006062750A1/fr
Publication of WO2006062750B1 publication Critical patent/WO2006062750B1/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
    • G01N21/359—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light using near infrared light
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/683—Means for maintaining contact with the body
    • A61B5/6832—Means for maintaining contact with the body using adhesives
    • A61B5/6833—Adhesive patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1495—Calibrating or testing of in-vivo probes

Definitions

  • the invention relates to optical sampling of tissue in-vivo. More particularly, the invention relates to an optical sampling interface system that includes an optical probe placement guide, a means for stabilizing the sampled tissue, an optical coupler for repeatably sampling a tissue measurement site in-vivo, and/or a means for compensating for measurement bias.
  • In-vivo measurement of tissue properties and analytes using optical based analyzers requires that a tissue measurement region be positioned and coupled with respect to an optical interface or probe.
  • the requirements of an optical sampling interface system for such placement and coupling depends upon the nature of the tissue properties and analytes under consideration, the optical technology being applied, and the variability of the tissue with respect to the target analyte.
  • the optical measurement is performed in a laboratory where the majority of the factors pertaining to the measurement are controlled or constrained.
  • there are many demanding in-vivo applications that cannot be performed in a laboratory setting, but yet require a high degree of optical sampling reproducibility. In one example, a relatively unskilled operator or user must perform the optical measurement.
  • One such application is the noninvasive estimation of glucose concentration through near-infrared spectroscopy.
  • the desired end result being an optical measurement system that is used by the consumer in a variety of environments, the optical sampling requirements are stringent. This problem is further considered through a discussion of the target application, the structure of live skin, and the dynamic properties of live tissue.
  • Diabetes is a chronic disease that results in abnormal production and use of insulin, a hormone that facilitates glucose uptake into cells. While a precise cause of diabetes is unknown, genetic factors, environmental factors, and obesity play roles. Diabetics have increased risk in three broad categories: cardiovascular heart disease, retinopathy, and neuropathy. Diabetics often have one or more of the following complications: heart disease and stroke, high blood pressure, kidney disease, neuropathy (nerve disease and amputations), retinopathy, diabetic ketoacidosis, skin conditions, gum disease, impotence, and fetal complications. Diabetes is a leading cause of death and disability worldwide. Moreover, diabetes is merely one among a group of disorders of glucose metabolism that also includes impaired glucose tolerance and hyperinsulinemia, which is also known as hypoglycemia.
  • the prevalence of individuals with diabetes is increasing with time.
  • the World Health Organization (WHO) estimates that diabetes currently afflicts 154 million people worldwide. There are 54 million people with diabetes living in developed countries. The WHO estimates that the number of people with diabetes will grow to 300 million by the year 2025. In the United States, 15.7 million people or 5.9 percent of the population are estimated to have diabetes. Within the United States, the prevalence of adults diagnosed with diabetes increased by 6% in 1999 and rose by 33% between 1990 and 1998. This corresponds to approximately eight hundred thousand new cases every year in America. The estimated total cost to the United States economy alone exceeds $90 billion per year. Diabetes Statistics, National Institutes of Health, Publication No. 98-3926, Bethesda, MD (November 1997).
  • near-infrared spectroscopy involves the illumination of a region of the body with near-infrared electromagnetic radiation, i.e. light in the wavelength range 700 to 2500 nm.
  • the light is partially absorbed and scattered, according to its interaction with the tissue constituents prior to being reflected back to a detector.
  • the detected light contains quantitative information that is based on the known interaction of the incident light with components of the body tissue including water, fat, protein, and glucose.
  • Previously reported methods for the noninvasive estimation of glucose concentration through near-infrared spectroscopy rely on the detection of the magnitude of light attenuation caused by the absorption signature of blood glucose as represented in the targeted tissue volume.
  • the targeted tissue volume is that portion of irradiated tissue from which light is reflected or transmitted to the spectrometer detection system.
  • the signal due to the absorption of glucose is extracted from the spectral measurement through various methods of signal processing and one or more mathematical models.
  • the models are developed through the process of calibration on the basis of an exemplary set of spectral measurements and associated reference blood glucose concentrations (the calibration set) based on an analysis of capillary (fingertip) blood, venous blood, and/or alternative site fluids.
  • NIRI Imaging
  • NIRS quantitation
  • the measurement is further complicated by the heterogeneity of the sample, the multi-layered structure of the skin, the rapid variation related to hydration levels, changes in the volume fraction of blood in the tissue, hormonal stimulation, temperature fluctuations, and changes in blood constituent concentrations. This is further considered through a discussion of the scattering properties of skin and the dynamic nature of the tissue.
  • Skin The structure and pigmentation of human skin varies widely among individuals, between different sites on the same individual, and within an individual over time.
  • Skin includes stratified layers, a cellular epidermis, and an underlying dermis of connective tissue. Below the dermis is a subcutaneous fatty layer or adipose tissue.
  • the epidermis is the thin outer layer that provides a barrier to infection and loss of moisture, while the dermis is the thick inner layer that provides mechanical strength and elasticity.
  • epidermis layer is 10 to 150 ⁇ m thick and is divided into three layers, the
  • basal, middle, and superficial layers border the dermis and contains pigment-forming melanocyte cells, keratinocyte cells, Langherhan cells and Merkel cells See F. Ebling, The normal skin, In: Textbook of Dermatology, A. Rook, D. Wilkinson, F. Ebling, eds., 3ed., pp.5 - 30, Blackwell Scientific Publishers, Oxford, England (1979).
  • An outer superficial layer is also known as the stratum corneum.
  • the stratum corneum the outermost layer of the mammalian epidermis, is formed and continuously replenished by the slow upward migration of aqueous keratinocyte cells from the germinative basal layer of the epidermis. It is replenished about every two weeks in mature adults. See W. Montagna, The Structure and Function of Skin, 2ed., p.454, Academic Press, New York, (1961). This complex process involving intracellular dehydration and synthesis of an insoluble protein, keratin, results in keratin-filled, biologically inactive, shrunken cells. These flat, dehydrated, hexagonal cells are tightly bound to their neighbors and each is approximately 30 ⁇ m wide and 0.8 ⁇ m
  • the major constituent of the dermis apart from water, is a fibrous protein, collagen, which is embedded in a ground substance composed mainly of protein and glycosaminoglycans.
  • the glycosaminoglycans play a key role in regulating the assembly of collagen fibrils and tissue permeability to water and other molecules. See K. Trier, S. Olsen, T. Ammitzboll, Acta. Ophthalmol., v. 69, pp.304 to 306 (1990).
  • Collagen is the most abundant protein in the human body.
  • Elastin fibers are also plentiful though they constitute a smaller proportion of the bulk.
  • the dermis also contains other cellular constituents and has a very rich blood supply, though no vessels pass the dermo-epidermal junction.
  • the blood vessels nourish the skin and control body temperature.
  • the thickness of the dermis ranges from 0.5 mm over the eyelid to 4 mm on the back and has an average thickness of approximately 1.2 mm over most of the body.
  • the spectral characteristics of water, protein, fat, urea, and glucose are all unique in the near-infrared from 1100 to 2500 nm.
  • Scattering is the primary process by which the beam is returned to the incident layer. Scattering results from differences in a medium's refractive index, corresponding to differences in the physical characteristics of the particles that make up the medium. The spatial distribution and intensity of scattered light depends upon the size and shape of the particles relative to the wavelength, and upon the difference in refractive index between the medium and the constituent particles.
  • the scattering coefficient of biological tissue depends on many uncontrollable factors, which include the concentration of interstitial water, the density of structural fibers, and the shapes and sizes of cellular structures. Scattering by collagen fibers is of major importance in determining the penetration of optical radiation within the dermis. See F. Bolin, L. Preuss, R. Taylor, R. Ference, Appl. Opt, v. 28, pp. 2297 to 2303 (1989).
  • the greater the diffusing power of a medium the greater the absorption related to multiple internal reflections. Therefore, reflectance values measured on different sites on the same person, or from the same site on different people, can differ substantially even when the target absorber is present in the same concentration.
  • tissue parameters such as gender, age, genetics, disease, and exogenous factors due to lifestyle differences.
  • tissue parameters such as gender, age, genetics, disease, and exogenous factors due to lifestyle differences.
  • skin thickness in humans is greater in males than females, whereas the subcutaneous fat thickness is greater in females.
  • collagen density the packing of fibrils in the dermis, is higher in the forearms of males than females. See S. Schuster, M. Black, E. McVitie, Br. J. Dermatol, v.93, pp.639 to 643, (1975).
  • Total body water accounts for over 60% of the weight of the average person and is distributed between two major compartments: the intracellular fluid (two-thirds of total body water) and the extracellular fluid (one-third of total body water). See A. Guyton, J. Hall, Textbook of Medical of Physiology. 9 th ed., Philadelphia, W.B. Saunders Company (1996).
  • the extracellular fluid in turn, is divided into the interstitial fluid, which is extravascular, and the blood plasma, which is intravascular. Water permeable lipid membranes separate the compartments and water is transferred rapidly between them through the process of diffusion to equalize the concentrations of water and other analytes across the membrane.
  • the net water flux from one compartment to another constitutes the process of osmosis, and the amount of pressure required to prevent osmosis is termed the osmotic pressure.
  • the fluid compartments Under static physiological conditions the fluid compartments are at equilibrium. However, during a net fluid gain or loss as a result of water intake or loss, all compartments gain or lose water proportionally and maintain a constant relative volume.
  • the cell membrane is relatively impermeable to most solutes but highly permeable to water, whenever there is a higher concentration of a solute on one side of the cell membrane, water diffuses across the membrane toward the region of higher solute concentration. Large osmotic pressures can develop across the cell membrane with relatively small changes in the concentration of solutes in the extracellular fluid. As a result, relatively small changes in concentration of impermeable solutes in the extracellular fluid, such as glucose, can cause tremendous changes in cell volume.
  • Noninvasive measurement of tissue properties and analytes, such as blood glucose concentration may employ near-infrared (near-IR) spectroscopic methods.
  • near-IR near-infrared
  • S. Malin, T. Ruchti, supra describes a system for noninvasive ⁇ estimating blood glucose concentrations in-vivo, using near-infrared spectral analysis.
  • Such near-infrared spectroscopy-based methods use calibrations that are developed using repeated in-vivo optical samples of the same tissue volume. Repeatability of these successive measurements is needed to produce a usable calibration.
  • the heterogeneous and dynamic nature of living human skin leads to sampling uncertainty in the in- vivo measurement. Sampling differences can arise due to variable chemical composition and light scattering properties in tissue.
  • a variation in the volume of tissue sampled is likely to lead to a variation in the strength of the glucose signal, even though glucose concentration in the tissue or blood remains constant.
  • Variation in the repeated placement of the optical probe used for sampling at the measuring surface site can lead to sampling errors in two separate ways. First, variations in the location of the probe can cause a different tissue volume to be sampled and, second, varying the amount of pressure applied by the probe on the tissue can alter the optical scattering by the tissue, thereby changing the sampled tissue volume.
  • a change in optical sampling may lead to a variation in the spectral signal for a target analyte, even though the concentration of the analyte in the blood or tissue remains unchanged.
  • variable surface reflection leads to a variable light launch into the tissue that, in turn, gives rise to an increase in nonlinear nature of the spectral measurements. Certainly, a variable nonlinear measurement is difficult to calibrate.
  • Kordis teachings are directed to surgical methods for the heart, and have nothing to do with optical sampling of tissue in-vivo. Furthermore, the apparatus of Kordis et al. is not suitable for repeatably coupling an optical probe to a tissue measurement site.
  • U.S. Patent No. 5,956,150 (September 21 , 1999) describes a method for using an illumination device, such as a laser to align two components during an assembly process.
  • the Kanne teachings are directed to a manufacturing process rather than optical sampling of tissue in-vivo.
  • the Kanne device does not provide any means for repeatably placing a probe guide at a tissue measurement site. It also lacks means for monitoring the surface temperature at a tissue measurement site and for minimizing surface temperature fluctuations and accumulation of moisture at a tissue measurement site.
  • U.S. Patent No. 5,448,662 disclose an optical fiber support that is coupled to a frame for positioning an optical fiber at a desired angular position.
  • Kittell et al. have nothing to do with optical sampling of tissue in-vivo.
  • the disclosed device allows an operator to immobilize an optical fiber so that it is maintained in a fixed position, but it lacks means of repeatably coupling a fiber optic probe to a tissue measurement site. It also has lacks means for monitoring the surface temperature at a tissue measurement site and for minimizing accumulated moisture and temperature fluctuations at the site.
  • a solution to the problem of controlling optical sampling during a noninvasive measurement must address several challenges posed by the structural characteristics and dynamic properties of living tissue, such as:
  • a placement guide for an optical probe that couples the probe to a tissue measurement site for in-vivo optical sampling of the tissue in a fashion allowing increased precision and accuracy of noninvasive analyte concentration estimations
  • An optical coupling medium to provide a constant interface between an optical probe and the skin at a tissue measurement site that is nontoxic and non-irritating and that does not introduce error into spectroscopic measurements; A means of monitoring surface temperature at the tissue measurement site, therefore assuring that the temperature remains constant across repeated optical samples; and
  • the invention provides an optical sampling interface system that minimizes sampling variation and/or state fluctuations at a measurement site, thereby allowing optical tissue sampling and subsequent noninvasive analyte concentration estimation with increased precision and accuracy.
  • Figure 1 is a perspective view of a glucose tracking system analyzer according to the invention
  • Figure 2 shows an optical probe placement guide according to the invention
  • Figure 3 provides a sample probe placement guide that uses a magnet according to the invention
  • Figure 4 shows a jig for sample probe registration that includes a rotational alignment control according to the invention
  • Figure 5 illustrates a guide for alignment of a sample probe to a tissue site with an aperture partially within the perimeter of the guide according to the invention
  • Figure 6 illustrates a guide for alignment of a sample probe to a tissue site with an aperture outside the perimeter of the guide according to the invention
  • Figure 7 illustrates a guide with two registration points for control of at least rotational alignment according to the invention
  • Figure 8 illustrates a guide for alignment of a sample probe to a tissue site with two separate alignment pieces according to the invention
  • Figure 9 illustrates a guide using magnets for alignment of a sample probe to a tissue site with two separate alignment pieces according to the invention
  • Figure 10 illustrates a guide with a layer between an alignment piece and a sample site according to the invention
  • Figure 11 illustrates a guide with two layers between an alignment piece and a sample site according to the invention
  • Figure 12 presents a guide with two layers between an alignment piece and a sample site interacting with a sample probe according to the invention
  • Figure 13 illustrates a guide with at least one flexible part according to the invention.
  • Figures 14 and 14b present a guide allowing a z-axis movable sample probe according to the invention.
  • the invention provides an optical sampling interface system, jig, or guide that eliminates or minimizes factors that account for sampling error.
  • An optical probe placement guide facilitates repeatable placement of an interfacing optic, such as an optical sample probe tip, with the surface of a tissue measurement site with a minimal degree of tissue distortion and displacement. Repeatable placement is also described as indexing a position or registering a position.
  • the major structural component of a probe placement guide is a mechanical interface of one or more guide elements with one or more corresponding sections of the interfacing sample probe.
  • the lock and key mechanism of the guide element(s) and the interfacing sample probe improves the precision of probe placement during the course of multiple measurements.
  • Different embodiments of the invention include a guide comprising any of:
  • An optional occlusive element placed over the tissue meniscus isolates the tissue meniscus from environmental fluctuations.
  • the occlusive element stabilizes and controls the temperature of the surface of the sample site and/or stabilizes the degree of hydration of the tissue meniscus and thereby stabilizes surface tension of the tissue meniscus.
  • An optional coupling medium placed on the surface tissue at the tissue measurement site eliminates sampling errors due to air gaps between the skin surface and the optical probe.
  • An optional measurement and bias correction element applies a bias correction to spectral measurements, and the associated analyte measurement. Precision in sampling location allows bias to be removed if a correction process, such as mean centering, is used in the algorithm. This is addressed in the preprocessing section below. Such bias corrections are performed for example, with all data taken over the course of one guide placement or until another reference concentration is determined. When the guide is removed and replaced, a new bias correction is preferably determined for all subsequent data taken with the second guide placement.
  • each of the separate elements of the invented system can be individually deployed as standalone solutions to counter various sources of measurement error.
  • the probe placement guide independent of the other elements of the system, provides a significant reduction in sampling error.
  • the occlusive element provides a significant reduction in measurement error due to state fluctuations at the surface of the measurement site.
  • the correction algorithm can be applied to spectral measurements in settings lacking the other elements of the system.
  • An analyte detection and/or concentration tracking system is used, such as a glucose tracking system.
  • a glucose concentration tracking system uses a glucose concentration analyzer that comprises at least a source, a sample interface, at least one detector, and, a system for implementing an associated algorithm.
  • an analyzer 10 is separated into elements including a base module 11 , a communication bundle 12, and a sample module 13. The advantages of separate units are hereinafter described.
  • the sample module also referred to as a sampling module, interfaces with a tissue sample and at the same or different times with one or more reference materials.
  • the base module 11 , communication bundle 12, sample module 13, and system for implementing the algorithm are referred to as a spectrometer and/or analyzer 10.
  • the base module and sample module are in separate housings.
  • Providing separate housings for the sample module and base module has multiple benefits, such as thermal, size, and weight management.
  • the sample module is allowed to be smaller and weigh less without the bulk of the base module. This allows easier handling by the user and less of a physical impact on the sample site by the sample module.
  • heat from a source in one housing is separated from a detector in a second housing, allowing for ease in cooling the detectors, thereby resulting in lower detector noise.
  • the sample module, base module, and communication bundle are further described, infra.
  • all of the components of a noninvasive glucose analyzer are included in a single unit, such as a professional use analyzer, a stand-alone analyzer, or a handheld analyzer.
  • the sample module includes a sensor head assembly that provides an interface between the glucose concentration tracking system and the patient.
  • the tip of the sample probe of the sample module is brought into contact with the tissue sample.
  • the tip of the sample probe is interfaced to a guide, such as an arm-mounted guide, to conduct data collection and removed when the process is complete.
  • Guide accessories include an occlusion plug that is used to fill the guide cavity when the sensor head is not inserted in the guide, and/or to provide photo-stimulation for circulation enhancement.
  • the following components are included in the sample module sensor head assembly: a light source, a single fiber optic, and coupling fluid.
  • the sample module is in a separate housing from the base module.
  • the sample module is integrated into a single unit with the base module, such as in a handheld or desktop analyzer.
  • the communication bundle is wireless or is integrated into the analyzer,
  • the communication bundle is a multi-purpose bundle.
  • the multipurpose bundle comprises a flexible sheath that comprises at least one of:
  • Thermistor wires • One or more fiber-optics, which direct diffusely reflected near-infrared light to the spectrograph;
  • a tube used to transport optical coupling fluid from the base unit, through the sensor head, and onto the measurement site;
  • the analyzer is packaged with labeling instructions to train the user not to twist the bundle and, optionally, mechanical means to prevent the bundle from twisting more than one-quarter turn in either direction.
  • a signal is communicated from the sample module to a base module.
  • a portion of the diffusely reflected light from the site is collected and transferred via at least one fiber-optic, free space optics, digitally after detection, or via an optical pathway to the base module.
  • the base module contains a spectrograph.
  • the spectrograph separates the spectral components of the diffusely reflected light, which are then directed to the photo-diode array (PDA).
  • PDA photo-diode array
  • the PDA converts the sampled light into a corresponding analog electrical signal, which is then conditioned by the analog front-end (AFE) circuitry.
  • AFE analog front-end
  • the digital data are then sent to the digital circuitry where they are checked for validity, processed, and stored in non-volatile memory.
  • the processed results are recalled when the session is complete and, after additional processing, the individual glucose concentrations are available for display or transfer to a personal computer.
  • the base module also, preferably, includes a central processing unit or equivalent for processors, memory, storage media for storing data, a model, a multivariate model, and/or analysis routines, such as those employing a model or net analyte signal.
  • a system is described herein that provides superior sampling precision of the target tissue volume through the use an optical probe placement guide or jig that is removably attached to the tissue site to achieve the goal of highly repeatable sample probe placement at a targeted tissue measurement site.
  • a key characteristic of the guide is that it provides a means for registering the location of the targeted tissue volume with respect to the optical probe and/or tip of a sample module, such that a particular tissue volume is precisely sampled by the optical system. Registration refers to providing feedback regarding the position of the optical probe relative to a target location on the tissue.
  • the means for registering between the guide and the optical probe may be mechanical, optical, electrical, and/or magnetic.
  • some embodiments of the invention allow for a more constant pressure/constant displacement to be applied to the sampling location which also enhances precision and accuracy of the glucose determination. While the guide greatly enhances positioning and allows associated data processing to be simpler and more robust, the guide is not an absolute requirement of the sampling module.
  • an x, y, and z coordinate system relative to given a body part is used.
  • the x-axis is along a body part, such as from an elbow to the wrist, from the shoulder to the elbow, or along the length of a digit of a hand.
  • the y-axis moves across a body part.
  • the x,y plane tangentially touches the skin surface, such as at a sample site.
  • the z-axis is normal to the x,y plane, such that an object moving toward the skin surface is moving along the z- axis.
  • a sample probe brought toward a sample site is moving along roughly the z-axis.
  • a first embodiment of the invention comprises a guide 200, having an aperture 202, a mechanical stop 203, and an optional temperature probe opening or slot 208.
  • a guide 200 having an aperture 202, a mechanical stop 203, and an optional temperature probe opening or slot 208.
  • the guide at least partially surrounds an interfacing optic for the purpose of sampling in a precise location. Typically, this is done with an interface with defined points that interface part of the sample module, such as the sample probe in a lock and key fashion.
  • the guide 200 is provided in a number of shapes.
  • An oval outer perimeter of a guide is shown in Fig. 2. Additional shapes of the outer perimeter include a number of geometric shapes, such as rectangular, oval, circular, elongated, curved, or polygon.
  • the outer edge of the guide is beveled to prevent snagging, such as by loose clothing or by an outside object, such as a tabletop or arm support.
  • the outer edge of the guide on the outer surface, away from the sample site is preferably rounded or beveled to reduce weight.
  • the outer shape presented in Figure 2 approximates the surface of the sampled tissue site, for example, an oval guide is used with the volar or dorsal surface of the forearm.
  • other shapes are used for other locations of the body such as the hand, the earlobe, the leg, the abdomen, the upper arm region, and the fingers.
  • the guide comprises an aperture into which the optical probe is received.
  • the guide has an aperture 202, into which an optical probe is received.
  • the sizes and shapes of the optical probe and the guide aperture 202 are matched to each other such that when the optical probe is received by the guide, it fits snugly and provides a mechanical registration in the x-y plane relative to the tissue measurement site.
  • the aperture serves several purposes including at least one of: • A mechanical registration point;
  • the guide and the optical probe are equipped with mechanical stops 203 that limit and control the penetration of the optical probe into the tissue (the z-direction).
  • the weight of the tissue is transferred to the optical probe through the mechanical stop 203.
  • the weight is preferably distributed across the guide, as opposed to being on the sample site surface, thereby reducing the pressure at the tissue measurement site.
  • a flexible material or movable wings with some resistance are used to cushion the weight or distribute the weight of the sample probe, respectively. Guides with flexible materials are further described, infra.
  • the guide is, optionally, equipped with an opening 208 for the optional insertion of a temperature probe. This feature is particularly useful during the calibration phase for monitoring of skin temperature.
  • the analyzer or sample module couples with a guide that is semi-permanently attached to the skin with a replaceable adhesive layer 201.
  • the adhesive layer 201 resides between the inner surface of the guide 200 and the region about the sample site.
  • the adhesive layer is applied to the guide at the time of manufacture.
  • the adhesive layer is applied to the guide or tissue sample prior to usage.
  • the adhesive covers the entire inner surface of the guide, that surface of the guide that is in contact with the skin area adjacent to and surrounding the tissue measurement site.
  • other attachment means are suitable such as straps, suction, or armbands.
  • the guide is attached to the tissue site at the beginning of a measurement period or some time before the beginning of a measurement period, infra.
  • the guide is attached to the subject for a period of time, such as the waking hours of the subject. Typically, this period is the beginning of a particular day after a previously used guide has been removed.
  • the guide is alternatively attached for a shorter time period or in a more permanent fashion, such as for a day, week, or month, especially in continuous monitoring glucose analyzers discussed below.
  • the method of attachment is to place the guide 200 onto a noninvasive measurement device with the adhesive layer in place and exposed.
  • the tissue measurement site is then placed onto the guide. During this first placement, the guide becomes affixed to the tissue site.
  • the curvature of the guide surface contacting the tissue sample is a shape correlating to the tissue.
  • the inner surface or tissue side of the guide is preferably flat or nearly flat.
  • the inner surface of the guide has a curvature that complements the region of curvature about the sample, such as a radius of curvature of about 6, 4.5, 3, or 1.5 inches.
  • the inner surface of the guide has a curvature that complements the region of curvature about the sample, such as a radius of curvature of about 0.6, 0.4 or 0.2 inches.
  • a guide is intended to allow for comfortable and unobtrusive use without application of significant mechanical energy to the sampled tissue site.
  • the guide 200 allows for the distribution of mechanical energy transferred from the instrument to the arm over a greater area around the measurement site.
  • a guide is composed of a rigid polymer, allowing for the creation of a stable tissue meniscus.
  • the guide is composed of a flexible material, such as a flexible polymer, that provides for a stabilization of the measurement site and deformation of the underlying tissue without applying undue force to the
  • a flexible material such as SORBOTHANETM
  • the guide is partially made of a rigid material and partially made of a flexible material, such as having rigid elements for alignment and flexible elements for distribution of applied forces from the sample probe.
  • Other materials providing the requisite combination of rigidity and light weight, such as lightweight metals, are also suitable.
  • a second embodiment of the invention uses magnets to align a portion of a sample module to a sample site precisely and replaceably.
  • magnets 207 placed into a guide 200 and a device coupled to the guide is provided.
  • a plug 204 is pictured that has magnets corresponding to the magnets of the guide.
  • the sample module and/or one or more reference materials have magnets that correspond to the guide magnets.
  • Magnets are used for at least one of:
  • two magnets are used, one on each side of the sampled site, to enhance alignment.
  • One magnet coupled to a magnetizable material or a larger number of magnets are alternatively used to provide the same effect.
  • one or more magnets are electrically activated to facilitate a controlled movement of the probe into the guide aperture and to allow, through reversal of the magnet poles, the probe to be withdrawn from the guide without pulling on the guide. It is recognized that there exist a large number of alternative mechanical methods for coupling two devices together, such as lock and key mechanisms, electro-magnets, machined fits, VELCRO, adhesives, snaps, and many other related techniques commonly known to those skilled in the art.
  • a third embodiment provides a cover in the aperture of a guide, such as a window, a longpass filter, or a bandpass filter.
  • a window such as an optical window, allows light to penetrate through the guide while still providing control of the surface of the sample site, such as occlusion and temperature control of the sample site.
  • the aperture houses a removable plug.
  • the contact of a window or plug with the skin stabilizes the tissue by providing the same tissue displacement as the probe and increases the localized skin surface and shallow depth hydration.
  • use of a contact window allows a continuous barrier for proper hydration of the sampling site and a constant pressure interface.
  • the use of a plug or contact window leads to increased precision and accuracy in glucose determination by the removal of issues associated with dry or pocketed skin at the sampling site.
  • a fourth embodiment uses a guide that controls rotational freedom of a sample probe relative to the sample site. Rotational freedom is controlled using means that orient the sample probe in a certain direction relative to the guide, such as mechanical, electrical, or magnetic means.
  • a first half of a lock and key mechanism is on the guide and the corresponding half of a lock and key mechanism is on the sample probe.
  • the guide contains a mechanical extrusion, such as an isosceles triangle shaped post or a post or indentation with a single rotational degree of freedom, an indentation, or stop that limits the rotational orientation of the corresponding probe part.
  • a magnet such as a rod
  • a corresponding magnet such as a matching rod, is placed into the sample probe with a north and south pole in the opposite orientation.
  • Controlling the x-, y-, and z-position of a part does not necessarily control the rotational position of a part.
  • a top stays in the same x-, y, and z-position while spinning, yet the rotation varies.
  • controlling the rotation of the interfacing sample module or communication bundle is important and is not controlled by x-, y-, and z-positioning of the items relative to the guide.
  • Controlling rotation of the sample probe is important for a number of reasons.
  • photons are not evenly distributed across a cross-section of the optical path in most optically-based instruments.
  • hot spots exist that have a larger photon flux compared to other regions of the cross-section.
  • the incident photons from the source of a sample module are not evenly distributed without additional optics or great care and expense in alignment.
  • a shadow is created that creates a cool spot in the cross sectional profile of the incident optics.
  • rotation of the sample module interface moves the hot spot on the sampled tissue.
  • an incident optic and/or a collection optic is often physically attached to an additional part.
  • a source fiber is attached to a mount and a collection fiber is attached to a slit.
  • Rotation of the sample module causes rotation of the optics, such as a fiber optic.
  • rotation results in micro-cracking of the core of the fiber or of the cladding about the fiber. This results in lost photons and an imprecise reading with rotation.
  • interfacing optics are not necessarily symmetrical. For example, a sampling probe comprised of an excitation fiber and a collection fiber is not symmetrical.
  • FIG. 4 an example of a guide 200 with a mechanical registration piece 401 is presented.
  • the mechanical registration piece 401 limits rotational freedom of the corresponding part of a sample probe to a single orientation.
  • the tissue sample site 402 is accessed through an aperture 202 that is contained within the guide.
  • the x- and y- position of the sample probe is controlled relative to the guide and tissue sample site in an instance where the sample probe outer dimensions are tightly controlled to the aperture size.
  • An additional benefit of controlling rotational freedom is that one or more of the X-, y-, and z-positions of the sample probe are set while aligning the rotational orientation of the sample probe relative to the guide. For example, a magnet flush with the surface aligns at least the z-position or a corresponding sample probe that also has a magnet flush with the surface.
  • an extrusion from the guide or an indentation into the guide align the corresponding indentation or extrusion of a sample probe in one or more of the x-, y-, and z-positions.
  • the tissue sample site 402 is, optionally, in a region that is sampled through an aperture in a guide, in a region that is outside of the contact area of the guide with the sample, or is in a region partially within the guide.
  • FIG. 5 an example of a polygonal guide 200 with a polygonal mechanical registration piece 401 is presented, where the sample site is partially overlapping with the generic shape of the guide.
  • the corresponding sample probe has a tip that has a shape and or dimension that is different from the guide. At least the part of the sample probe that aligns to the registration piece 401 is complementary to the guide.
  • a separate section of the sample probe controls the incident and/or collection photons to a sample region 402 partially contained by the boundary of the guide.
  • the mechanical registration piece in this example controls the rotational orientation of the sample probe. In the instance where the registration piece is formed in three-dimensions and corresponds to a matching piece on the sample probe, the x-, y-, and z-position of the sample probe is also controlled versus the sample site.
  • FIG. 6 an example of a rectangular guide 200 with a magnetic registration piece 401 is presented where the sample site is outside of the region of the guide.
  • the magnetic registration piece in this example controls the rotational orientation of the sample probe through the magnetic alignment of the poles, as described heretofore.
  • a separate section of the sample probe controls the incident and/or collection photons to a sample region 402 outside the perimeter of the guide footprint.
  • the registration piece controls the z- position of the sample probe relative to the sample site.
  • a fifth embodiment of the invention includes a guide with at least two registration pieces.
  • a guide 200 is presented that has a first registration piece 701 and a second registration piece 702.
  • the two registration pieces on the guide control at least one of the X-, y-, and z-position, as well as the rotational alignment of the corresponding sample probe.
  • the first alignment piece controls at least the x-position and y-position of the sample probe and the second alignment piece controls the z-position.
  • the two alignment pieces control the rotational alignment of the sample probe.
  • the first registration piece and second registration piece each control one or more of the x-position, y-position, z-position, and rotational alignment of the sample probe.
  • the first and second registration pieces combined control any of the x-position, y-position, z-position, and rotational alignment of the corresponding sample probe.
  • a sixth embodiment of the invention uses a guide comprising two or more separate pieces, where each piece is semi-permanently and replaceably attached to a region about the sample site.
  • a guide comprising a first alignment piece 801 and a second alignment piece 802 is presented.
  • part of a housing of a sample probe 803 is presented.
  • the sample probe is of any design.
  • the aperture of the housing contains interfacing optics, such as illumination and collection optics.
  • Optional magnets 207 are provided.
  • an example of an optional registration indentation 804 is presented.
  • the first alignment piece 801 has registration points that control at least two of the X-, y-, and z-positions of the coupled sample probe.
  • the first alignment piece has a mechanical stop, such as a post.
  • the sample probe has a corresponding mechanical stop, such as a post hole.
  • the post sets into the post hole in a lock and key fashion.
  • the x-, y-, and z-positions of the sample probe are hence registered to a fixed position relative to the first alignment piece.
  • the first alignment piece is one half of a lock and key mechanism, such as a ridge, that controls the x-, and z-position of the sample probe, which has the second half of a lock and key mechanism.
  • the z-position of the sample probe is not controlled because the trough on the sample probe that corresponds to the ridge on the alignment piece has freedom of movement along the y-axis.
  • a third example addresses the instance where a single alignment lock mechanism with rotational symmetry, such as a post, still allows rotational freedom.
  • the first alignment piece has one-half of a lock and key mechanism that does not have rotational symmetry, such as an isosceles triangle indentation.
  • the sample probe has a second half of the lock and key mechanism corresponding to that of the first alignment piece, such as an isosceles triangle extrusion that fits into the oval indentation.
  • the x-, y-, and z-position and the rotational orientation of the sample probe are fixed relative to the sample site when aligned versus the first alignment piece.
  • Additional registration means include ball bearings, kinematic mounts, hinges, slides, extrusions, indentations, and mechanical stops.
  • the second alignment piece 802 has means for registering the sample probe in any of the ways described, supra, for the first alignment piece.
  • the second alignment piece controls at least one of the x-position, y-position, z-position, and rotational alignment of the corresponding sample probe.
  • a benefit of using two alignment pieces for a guide is that the sample is not fixed in size and/or orientation with time.
  • skin expands and contracts due to physical responses to outside parameters, such as fluid intake, hydration, body temperature, and environmental temperature.
  • a one piece guide causes the skin to stretch, which results in a changed optical pathlength and sampled volume by probing photons.
  • the skin layers such as the epidermal and dermal layers, get thinner. This results in more photons penetrating through to the fat layer.
  • the spectral features observed change, often with a loss of precision and/or accuracy of the corresponding glucose concentration estimations.
  • the first alignment piece has a post 804 that controls the x-, y-, and z- position of the corresponding sample probe.
  • the second alignment piece is a slide that controls the y-position and z- position of the corresponding sample probe.
  • the sample probe aligns to the post of the first alignment piece.
  • the sample probe also aligns to the y- position and z-position of the second alignment piece.
  • the second alignment piece allows freedom of motion in the y-position.
  • the first alignment piece also controls the rotational freedom of the sample probe as described, supra.
  • an aperture of the sample probe creates a meniscus about the sample site at time of sampling. Additional permutations and combination means for registering the sample probe relative to the first alignment piece are possible.
  • the first alignment piece contains an optional magnet 901 that registers at least the x-, y-, and z-position of the sample probe.
  • the second alignment piece also contains an optional magnet 902 and is used to register at least the y- and z- position of the sample probe.
  • the first and second alignment pieces 801 , 802 are optionally attached directly to a tissue sample site or a region about the sample site, as described supra. In another instance, one or more intermediate layers are placed between the first and second alignment pieces 801 , 802 and the tissue sample.
  • a first layer 1001 is places on the sample side of the first and second alignment pieces 801 ,802.
  • the first layer is a material that covers at least part of the space between the alignment pieces and the tissue sample.
  • first layers configurations are provided.
  • the first layer 1001 is an adhesive, as described heretofore.
  • part of the first layer 1001 is composed of a flexible material 1002, such as acetate.
  • the flexible layer forms a living hinge, which helps to adapt the guide 200 to the changing shape of skin tissue and helps the guide 200 fit a curved surface.
  • the living hinge also serves to distribute the weight of the guide and/or sample probe across a greater region of the skin tissue, especially as the sample probe is removed and replaced resulting in weight changes on or about the sample site.
  • the weight of the sample probe is distributed by the guide off of the sample site that is optically probed.
  • a separation section 1003 of the first layer is used to separate an adhesive layer from the sample probe, such as polytetrafluoroethylene.
  • a first section 1002, such as a flexible material section, and a second section 1003, such as a separation section are both used in the first layer 1001.
  • the first and second sections 1002, 1003 are separated by a gap 1004. The gap allows the first layer to expand, contract, twist, and/or deform as the skin tissue shape changes.
  • the first layer serves at least one of several purposes.
  • the first layer 1001 covers at least a portion of the second layer 1101 , described infra, and protects the surface of the sample probe from the first layer.
  • the first layer 1001 is optionally separated into regions that are not attached by one or more small gaps 1004 allowing for fewer restraints on the skin tissue and hence fewer changes in the optical properties of the skin that affect optical based analyte concentration estimations.
  • a second layer 1101 is placed on the sample side of the first layer.
  • the second layer is either replaceably attached or permanently attached to the first layer.
  • the second layer contains one or more sublayers.
  • a single sub-layer is used, such as an adhesive layer used to attach either the attachment pieces 801 , 802 or the first layer 1001 to the tissue sample.
  • three sub-layers are used, such as a substrate layer sandwiched by an adhesive layer on either side.
  • a third case uses a peel-off layer on one or both sides of additional sub-layers for ease of attachment to any of the skin tissue, attachment pieces 801 ,802, or first layer.
  • a peel-off layer 1103 is on the sample side of the second layer 1101 and the second layer contains at least an adhesive layer 1102.
  • An example of the guide presented in Figure 11 interacting with a tip of a sample probe is illustrated in Figure 12.
  • a particular embodiment uses a guide 200 that comprises at least a first and a second alignment piece 801 ,802.
  • a preferable embodiment also includes a first layer 1001 and a second layer 1101.
  • a guide 200 that includes at least a first and a second alignment piece 801 ,802 is available as a disposable item in a kit.
  • the kit includes one or both of a first layer 1001 and an adhesive layer 1101.
  • each of the two alignment pieces contains wings 1301.
  • the wings are attached to the alignment pieces with a flexible material 1302, such as a living hinge.
  • the living hinge compensates for changes in at least one of shape, weight, and applied pressure.
  • means for alignment of at least one of an x- position, y-position, z-position, and rotational position are provided jointly by the two alignment pieces and/or separately be each of the alignment pieces.
  • rotation of the sample probe is controlled by the guide while allowing z-axis movement of the guide.
  • the sample module 103 includes a sample probe 1403.
  • a controller 1401 controls an actuator 1402 that moves the sample probe 1403.
  • Signal processing means result in a control signal that is transferred from the controller 1401 to the sample probe 1403 typically through an actuator 1402.
  • the communicated control signal is used to control the z-axis movement of at least part of the sample module 103 relative to the tissue sample 104 or reference material.
  • the part of the sample module movable along the z-axis is referred to as the sample probe or sampling probe 1403.
  • the controller sends the control signal from the algorithm to the sample module actuator, preferably via a communication bundle.
  • the controller 1401 receives input from the sample probe or other sensor and uses the input to move the actuator 1402.
  • the controller is in different locations within the analyzer, such as in the sample module 103 or in the base module 101.
  • the actuator 1402 subsequently moves the sample probe 1403 relative to the tissue sample site 104.
  • no controller or actuator is used and the sample probe moves in response to gravity.
  • the sample probe 1403 is typically controlled along the z-axis from a position of no contact, to a position of tissue sample contact, and optionally to a position of tissue sample displacement.
  • the sample probe 1403 is presented in Figure 14 at a first (Fig 14a) and second (Fig. 14b) instant of time with the first time presenting the sample probe when it is not in contact with the sample site.
  • the second time presents the sample probe with minimal displacement of the sample tissue.
  • the sample probe is, optionally, moved toward the sample, away from the sample, or remains static as a function of time as discussed, infra.
  • An optional guide is attached to the sample and/or reference.
  • Input to the controller includes a predetermined profile, an interpretation of spectral data collected from the sample probe, or input from a sensor, such as a pressure sensor, an optical sensor, or a thermal sensor.
  • the guide provides a means for optical registration.
  • reflectors or light sensitive elements are placed onto the guide.
  • the optical probe assembly is equipped with light sources and several detectors that allow the position of the guide to be accurately assessed, in either two or three dimensions. In a first configuration, two dimensions (x,y) are assessed and a mechanical stop is used to control the third dimension. In a second configuration, the location of the guide is optically assessed in all three dimensions (x,y,z). Because the position of the guide is constant with respect to the targeted tissue volume, the positional assessment provides accurate information regarding the location of the targeted tissue volume with respect to the optical probe. The registration information provided by such assessment is used to place the tissue site onto the optical probe, or vice versa, through any of the following means:
  • a mechanical positioning system is used to position the tissue measurement site with respect to the optical probe; or • A mechanical positioning system is used to position the optical probe onto the tissue measurement site.
  • the guide contains any of a number of elements designed to enhance equilibration between the glucose concentration at the tissue sample site and a capillary site, such as the fingertip. Rapidly changing glucose concentrations as a function of time can lead to significant discrepancies between alternate site blood glucose concentration and traditional blood glucose concentrations, such as from a well perfused region such as finger. The concentration differences are directly related to diffusion and perfusion that combine to limit the rate of the equilibrium process. Equilibrium between the two sites allows for the use of glucose-related signal measured at an alternate site to be more accurate in estimation of finger blood glucose concentration.
  • a number of elements are, optionally, incorporated into the sample module and/or guide to increase sampling precision and to increase the net analyte signal for a glucose concentration estimation. These optional elements are preferably powered through the base module and communication bundle, but are alternatively battery operated. Equalization approaches include photonic stimulation, ultrasound pretreatment, mechanical stimulation, and heating and are described, infra. Notably, equilibration of the glucose concentration between the sampled site and a well-perfused region such as an artery or the capillary bed of the fingertip is not required. A minimization of the difference in glucose concentration between the two regions aids in subsequent glucose concentration determination.
  • the guide optionally contains one or more light emitting diodes (LEDs) that provide photonic stimulation at wavelengths that induce capillary blood vessel dilation.
  • LEDs light emitting diodes
  • Photostimulation is used to aid in equilibration of alternative site glucose concentrations with those of capillary blood.
  • the preferred embodiment uses LEDs at about 890 nm in an array with control electronics set into the arm guide.
  • Other example wavelengths include about 910 nm, or at regions where water or another sample constituent strongly absorb.
  • the LED's are alternatively used in a continuous monitoring application where they are located in the probe sensing tip at the tissue interface. Due to the periods of excitation required for stimulation, the 890 nm LED is preferably powered by a rechargeable battery in the guide so that the LED may be powered when the communication bundle is not used.
  • the guide optionally contains an apparatus capable of delivering ultrasound energy into the sample site. Again, this technique is used to aid in equilibration of alternative site glucose concentrations with those of capillary blood by stimulating perfusion and/or blood flow.
  • the guide optionally contains an apparatus that provides mechanical stimulation of the sampled site prior to spectral data acquisition.
  • an apparatus that provides mechanical stimulation of the sampled site prior to spectral data acquisition.
  • One example is a piezoelectric modulator than pulses in an out relative to the skin surface a distance of about 5 to 60 ⁇ m and preferably 20 to 50 ⁇ m in a continuous or duty cycle fashion.
  • the guide optionally contains a heating and/or cooling element, such as a strip heater or an energy transfer pad.
  • Heating is one mechanism of glucose compartment equilibration. These elements are used to match the core body temperature, to manipulate the local perfusion of blood, to avoid sweating and/or to modify the distribution of fluids among the various tissue compartments.
  • the guide and/or plug contains a heating element that warms the nominally cooler skin surface to approximately body temperature. Example temperatures are about 88, 90, 92, 94, 96, and 98 degrees Fahrenheit.
  • the capillaries are dilated and glucose concentrations at the sample site to correlate with glucose concentrations in venous or well perfused capillary regions. It is recognized that the sampling module is optionally brought into contact with the sample site without the use of a guide.
  • a guide aperture is filled with a removable plug.
  • the contact of a window or plug with the skin stabilizes the tissue by providing the same tissue displacement as the probe and increases the localized skin surface and shallow depth hydration.
  • use of a contact window allows a continuous barrier for proper hydration of the sampling site and a constant pressure interface.
  • the use of a plug or contact window leads to increased precision and accuracy in glucose determination by the removal of issues associated with dry or pocketed skin at the sampling site.
  • an occlusion plug 204 is normally inserted into the aperture 202.
  • the occlusion plug penetrates into the aperture to the same extent as the optical probe and thereby creates a stable tissue state by simulating the contact energy of the optical probe.
  • the occlusion plug is composed of a material that provides a hydration barrier, thus promoting the full and stable hydration of the stratum corneum.
  • the plug is composed of the same material as the guide and possess a mechanical stop 205 to control the penetration into the tissue site.
  • the size of the portion of the plug that is inserted into the aperture 206 is matched to the portion of the optical probe that is received by the guide aperture 202.
  • Attachment of the plug to the guide may be through the use of one or more magnets located in both the guide and plug assemblies 207.
  • other methods of attachment may be used, such as hook and loop, adhesives, and snaps.
  • the plug can be composed of a material that is elastic in nature and is kept in place by virtue of its tight fit into the guide aperture.
  • the plug can be a hydrophobic material, such as cellophane.
  • an important aspect of the optical sampling system is the maintenance of an optimal level of hydration of the surface tissue at the measurement site for enhancement of the optical signal, sample reproducibility, and suppression of surface reflectance.
  • the preferred embodiment of the hydration mechanism is by occlusive blockage of trans-epidermal water loss. This blockage ensures a steady state hydration as water diffusing from interior tissue is trapped in the stratum corneum. Attainment of high hydration levels reduces the water concentration gradient that provides the driving force for this trans- epidermal water movement.
  • the above described occlusive plug fits snugly into the guide aperture during periods between measurements, acting to insulate the tissue in the guide aperture from trans-epidermal water loss and the environmental effects of temperature and humidity that are known to influence the stratum corneum hydration state.
  • wrapping a flexible polymer sheet (an occlusion patch) around the measurement site may also be used to attain a highly hydrated state via occlusion.
  • a vapor barrier or semi-permeable membrane for example, GORE-
  • the patch is affixed to the tissue site through an adhesive or other attachment mechanism such as a strap or a wrap;
  • Non-occlusive mechanisms for hydration of the stratum corneum may also be used, including:
  • Topical application of skin toners and other water/solute mixtures such as alpha hydroxy acid solutions that serve to drive water and solute into the dry outer skin layer;
  • Topical analgesic formulations that enhance and/or stimulate local circulation at the measurement site leading to an improvement in surface hydration.
  • the mechanisms for achieving stratum corneum hydration may also be used in coupled treatments.
  • skin toner solution or an ultrasound energy application may be used in conjunction with an occlusive plug.
  • subsequent measurements are made by placing the tissue site onto the noninvasive measurement device, after removing the occlusion plug and allowing the guide to provide mechanical registration. After the optical tissue measurement is performed, the tissue is taken away from the device and the occlusion plug is re-inserted.
  • the guide aperture induces the formation of a tissue meniscus, an upward bulge of tissue into the optical probe aperture.
  • the hydrostatic pressure within the tissue in the aperture is greater than that on the nude (guideless) tissue sample. This increased hydrostatic pressure absorbs energy translated to the tissue when the probe contacts the tissue, thus limiting the resulting distortion of dermal collagen tissue. Distortion of derma! collagen has a strong effect on the tissue optical properties and thus the sampled tissue volume. To achieve this correction, the termination of the optical probe should be flush with the contact surface at the tissue measurement site when the optical probe is fully seated.
  • the interface between the optical probe and the skin surface at the tissue measurement site can also be a significant source of sampling error. Because the underlying tissue is not homogenous, the surface skin at the tissue measurement site may be uneven, with frequent irregularities. Coupling the relatively smooth surface of the optical probe with the irregular skin surface leads to air gaps between the two surfaces. The air gaps create an interface between the two surfaces that adversely affects the measurement during optical sampling of tissue. An amount of a coupling medium such as a coupling fluid between the optical probe and the skin of the tissue measurement site or sample site eliminates such gaps.
  • the coupling fluid :
  • the active components of the coupling fluid from the class of compounds called perfluorocarbons, i.e. those containing only carbon and fluorine atoms.
  • Nominally limiting chain length to less than twenty carbons provides for a molecule having the requisite viscosity characteristics.
  • the molecular species contained in the perfluorocarbon coupling fluid may contain branched or straight chain structures.
  • a mixture of small perfluorocarbon molecules contained in the coupling fluid as polydisperse perfluorocarbons provides the required characteristics while keeping manufacturing costs low.
  • the coupling fluid is a perfluoro compound, a fluorocarbon, a perfluorocarbon, or a narrowly defined group of fluorocarbons in terms of viscosity, such as those known as FC-40 and FC-70, manufactured by 3M Corporation (St. Paul, MN).
  • FC-40 and FC-70 manufactured by 3M Corporation (St. Paul, MN).
  • the sampling fluid be formulated without the addition of other substances, such as alcohols or detergents, which may introduce artifacts into the optical sample.
  • the exceptional stability of perfluoro compounds eliminates the environmental hazard commonly associated with chlorofluorocarbons.
  • compositions containing perfluorocarbons and chlorofluorocarbons are also suitable as coupling fluids.
  • a blend of 90% polymeric chlorotrifluoroethylene and 10% other fluorocarbons has the desired optical characteristics.
  • Chlorotrifluoroethylene could also be used. While these compositions have the desired optical characteristics, their toxicity profiles and their solvent characteristics render them less desirable than the previously described perfluoro compounds.
  • fluid media are suitable for coupling of an optical probe to a tissue measurement site, for example, skin toner solutions or alpha hydroxy- acid solutions.
  • a quantity of sampling fluid is placed at the interface of the tissue measurement site and the fiber optic probe so that the tissue measurement site and the fiber optic probe may be tightly coupled without leaving any air spaces between the two surfaces.
  • one convenient way of placing the quantity of the sampling fluid at the interface between the tissue measurement site and the probe is to place a small amount of the fluid on the skin surface prior to placing the fiber optic probe, although it is easier to place it on the fiber-optic probe.
  • non-fluid media having the requisite optical characteristic of being near-infrared neutral are also suitable as coupling media, for example, a GORE-TEX membrane interposed between the probe and the surface of the measurement site, particularly when used in conjunction with one of the fluid media previously described.
  • bias correction is preferably made to the measurement to account for variations in the size of the meniscus caused by the guide installation.
  • a noninvasive measurement system provides a tissue measurement, m ⁇ !R ⁇
  • N corresponds to the dimensionality of the measurement.
  • m refers to the intensity spectrum of the tissue sample
  • m 0 a background or reference, is used to standardize or normalize the tissue measurement according to the calculation
  • m 0 is an estimate of light incident on the sample
  • m is an intensity
  • a is analogous to an absorbance spectrum containing quantitative information that is based on the known interaction of the incident light with components of the body tissue.
  • tissue measurement, m can be used directly instead of a.
  • the standardized tissue measurement, a is preferably preprocessed to attenuate noise and to reduce the interference related to surface reflectance, tissue volume distortion, and instrumental effects to produce the processed tissue measurement, x.
  • the preprocessing steps include calculating the first derivative, selecting specific wavelengths and wavelength regions specific to the analyte of interest, and performing scatter correction or multiplicative scatter correction.
  • a bias correction step follows the preprocessing steps defined above through the determination of the difference between the preprocessed estimated tissue background - the tissue template, and x through
  • x is the preprocessed tissue measurement or the selected set of
  • x f is the estimated background or tissue template associated with the current guide placement
  • c and d are slope and intercept adjustments to the tissue template.
  • the tissue template is determined through one or more tissue measurements (after preprocessing) and a data selection criterion for example by selecting only tissue measurements that resemble each other closely and averaging them.
  • x r is calculated from a single tissue measurement that
  • bias correction is referred to as bias correction and involves both:
  • the reference analyte values are determined from an electrochemical analysis of blood draws.
  • the analyte values are combined, according to the same strategy as that used to create the tissue template to form an analyte measurement bias adjustment, b, through the equation
  • g: dl M ⁇ $ ⁇ 1 is a calibration model used to map z to an estimate of the
  • the model is determined from a calibration set of exemplary paired data points, each consisting of a pre-processed and bias corrected tissue measurement (z) and an associated reference analyte value (y)
  • blood, serum, plasma, or interstitial draws are taken from a tissue site that is either near the sensor sample site or has been designed/determined to reflect the sample site.
  • tissue site that is either near the sensor sample site or has been designed/determined to reflect the sample site.
  • noninvasive near-infrared measurements for the purpose of glucose measurement are taken for calibration on the forearm, it is possible in some individuals to collect a capillary blood draw from the same forearm or an alternate site such as opposite forearm.
  • the method for designing the structure of g is through the process of system identification [L.
  • model parameters are calculated using known methods including multivariate regression or weighted multivariate regression [N. Draper, H. Smith, Applied Regression Analysis, 2d.ed., John Wiley and Sons, New York (1981)], principal component regression [H. Martens, T. Naes, Multivariate Calibration, John Wiley and Sons, New York (1989)], partial least squares regression [P. Geladi, B. Kowalski, Partial least-squares regression: a tutorial, Analytica Chimica Acta, 185, pp.1-17, (1986)], or artificial neural networks [S.
  • Calibration data must also be bias corrected if data contains subsets associated with different guide placement events.
  • the bias corrected tissue measurements undergo an outlier detection step.
  • the necessity for outlier detection and the form of an outlier detection procedure are dependent on the sampling technology employed.
  • Outlier detection provides a method of detecting invalid measurements through spectral variations that result from problems in the instrument, poor sampling of the subject or a subject outside the calibration set.
  • One method of detecting outliers is through a principal component analysis and an analysis of the residuals.
  • Near-infrared spectra were collected using a custom built scanning near-infrared spectrometer that collected intensity spectra in diffuse reflectance over the wavelength range 1100-1950 nm.
  • the spectral sampling interval was one nanometer and the signal-to-noise ratio at the peak intensity was approximately 90 dB.
  • InGaAs Indium- Gallium-Arsenide
  • the instrument collected intensity spectra in diffuse reflectance from the forearm in the wavelength range 1050-2450 nm.
  • the spectral sampling interval was 1 nm and the signal-to-noise ratio at the peak intensity was approximately 90 dB.
  • the detectors used in the study were a combination of Indium-Gallium-Arsenide (InGaAs) and extended InGaAs detectors.
  • the optical configuration consisted of a simple fiber-optic interface to the skin with a small ( ⁇ 2 mm) distance between the illumination and detection fibers.
  • 60 measurements were performed on a single subject.
  • 60 samples were collected using the guide positioning system without occlusion and absorbance was calculated as previously described.
  • 60 samples were collected with the use of both the guide positioning system and the preferred method of occlusion, i.e. a plug in the guide aperture.
  • the decrease in surface variation associated with the water bands demonstrated the improved optical sampling realized as a result of the method of occlusion.
  • the invented optical probe placement guide allows highly repeatable probe placement at a targeted tissue measurement site
  • the invention may also be used to produce small sampling variations in a controlled manner by shifting the placement of the optical probe in known increments across successive optical samples.
  • the invention provides a means of limiting sampling errors during in-vivo spectroscopic examination of tissue samples by providing highly repeatable optical probe placement at a targeted tissue measurement site.
  • Embodiments of the invention use a guide that does at least one of:
  • Structural features of the invention minimize temperature fluctuations and variable stratum corneum hydration at the tissue measurement site.
  • structural features of the invention minimize variations in optical probe placement and variations due to tissue distortion and displacement.
  • An optional temperature probe in direct contact with the skin surface at the tissue measurement site allows the monitoring of skin temperature across successive measurements.
  • An optical coupling fluid eliminates air spaces at the interface of the skin surface of the tissue measurement site and the optical probe.
  • a fully hydrated stratum corneum is attained by the use of an occlusive plug or other mechanism.
  • spectral measurements, and resulting analyte measurements are bias corrected to compensate error resulting from guide placement. While the invented optical sampling interface system has been herein described in relation to optical sampling of tissue, one skilled in the art will appreciate that the invention may be applied in other settings requiring repeatable placement of an optical probe.
  • each of the elements of the optical probe placement guide measurement system herein described are individually beneficial to the measurement and therefore can be used with or without the other elements.
  • the guide, the hydration control system, the coupling fluid, and the bias correction are uniquely beneficial.
  • the hydration control process, bias correction, and the coupling fluid are still beneficial.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Surgery (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Optics & Photonics (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Abstract

La présente invention concerne un système à interface d'échantillonnage optique qui réduit et corrige les erreurs imputables aux écarts d'échantillonnage et aux fluctuations d'état du site de mesures. Des modes de réalisation utilisent un guide qui est capable de l'une au moins des fonctions suivantes : induire la formation d'un ménisque de tissu, réduire les parasites imputables aux irrégularités de la surface, limiter les écarts du volume de tissu échantillonné, utiliser un système de guide en deux parties, utiliser un guide qui limite la rotation d'une sonde d'échantillon en permettant la translation verticale de la sonde, utiliser un module de base séparé du module échantillon en relation avec un guide, et utiliser un guide qui limite la rotation. L'invention concerne également des composants facultatifs tels qu'un élément occlusif et un couplage.
PCT/US2005/042738 2000-05-02 2005-11-23 Systeme a interface d'echantillonnage optique pour mesures de tissus in vivo WO2006062750A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP05825413A EP1824378A4 (fr) 2004-12-08 2005-11-23 Systeme a interface d'echantillonnage optique pour mesures de tissus in vivo
JP2007545509A JP2008522726A (ja) 2004-12-08 2005-11-23 組織の生体内測定のための光サンプリングインタフェースシステム

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US09/563,782 US6415167B1 (en) 2000-05-02 2000-05-02 Fiber optic probe placement guide
US36288502P 2002-03-08 2002-03-08
US10/170,921 US7206623B2 (en) 2000-05-02 2002-06-12 Optical sampling interface system for in vivo measurement of tissue
US10/472,856 US7133710B2 (en) 2002-03-08 2003-03-07 Compact apparatus for noninvasive measurement of glucose through near-infrared spectroscopy
US11/008,001 2004-12-08
US11/008,001 US7606608B2 (en) 2000-05-02 2004-12-08 Optical sampling interface system for in-vivo measurement of tissue

Publications (2)

Publication Number Publication Date
WO2006062750A1 true WO2006062750A1 (fr) 2006-06-15
WO2006062750B1 WO2006062750B1 (fr) 2006-07-27

Family

ID=56290756

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/042738 WO2006062750A1 (fr) 2000-05-02 2005-11-23 Systeme a interface d'echantillonnage optique pour mesures de tissus in vivo

Country Status (1)

Country Link
WO (1) WO2006062750A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015536713A (ja) * 2012-11-06 2015-12-24 ネモデバイシズ アクチェンゲゼルシャフトＮｅｍｏｄｅｖｉｃｅｓ Ａｇ 脳パラメータを決定するための測定装置

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5825488A (en) * 1995-11-18 1998-10-20 Boehringer Mannheim Gmbh Method and apparatus for determining analytical data concerning the inside of a scattering matrix
US5879373A (en) * 1994-12-24 1999-03-09 Boehringer Mannheim Gmbh System and method for the determination of tissue properties
WO2000076575A2 (fr) * 1999-06-11 2000-12-21 Spectrx, Inc. Dispositifs integres d'alignement, systemes et procedes destines a l'extraction efficace de fluide, a l'administration de substances et autres applications
US6381489B1 (en) * 1995-10-31 2002-04-30 Kyoto Daiichi Kagaku Co., Ltd. Measuring condition setting jig, measuring condition setting method and biological information measuring instrument

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5879373A (en) * 1994-12-24 1999-03-09 Boehringer Mannheim Gmbh System and method for the determination of tissue properties
US6381489B1 (en) * 1995-10-31 2002-04-30 Kyoto Daiichi Kagaku Co., Ltd. Measuring condition setting jig, measuring condition setting method and biological information measuring instrument
US5825488A (en) * 1995-11-18 1998-10-20 Boehringer Mannheim Gmbh Method and apparatus for determining analytical data concerning the inside of a scattering matrix
WO2000076575A2 (fr) * 1999-06-11 2000-12-21 Spectrx, Inc. Dispositifs integres d'alignement, systemes et procedes destines a l'extraction efficace de fluide, a l'administration de substances et autres applications

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1824378A4 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015536713A (ja) * 2012-11-06 2015-12-24 ネモデバイシズ アクチェンゲゼルシャフトＮｅｍｏｄｅｖｉｃｅｓ Ａｇ 脳パラメータを決定するための測定装置

Also Published As

Publication number Publication date
WO2006062750B1 (fr) 2006-07-27

Similar Documents

Publication Publication Date Title
US7606608B2 (en) Optical sampling interface system for in-vivo measurement of tissue
US7206623B2 (en) Optical sampling interface system for in vivo measurement of tissue
US6990364B2 (en) Noninvasive measurement of glucose through the optical properties of tissue
US7039446B2 (en) Indirect measurement of tissue analytes through tissue properties
US20060211931A1 (en) Noninvasive analyzer sample probe interface method and apparatus
US7697966B2 (en) Noninvasive targeting system method and apparatus
Do Amaral et al. Current development in non-invasive glucose monitoring
US20050187439A1 (en) Sampling interface system for in-vivo estimation of tissue analyte concentration
US20050054908A1 (en) Photostimulation method and apparatus in combination with glucose determination
US20050010090A1 (en) Compact apparatus for noninvasive measurement of glucose through near-infrared spectroscopy
US20050107676A1 (en) Method and apparatus for noninvasive glucose concentration estimation through near-infrared spectroscopy
Losoya-Leal et al. State of the art and new perspectives in non-invasive glucose sensors
WO2009136311A2 (fr) Commande de pression de contact pour sonde pour analyse de matériau
US8126527B2 (en) Method and system for determining the contribution of hemoglobin and myoglobin to in vivo optical spectra
WO2006062750A1 (fr) Systeme a interface d'echantillonnage optique pour mesures de tissus in vivo
EP1824378A1 (fr) Systeme a interface d'echantillonnage optique pour mesures de tissus in vivo
Paunescu et al. In-vitro correlation between reduced scattering coefficient and hemoglobin concentration of human blood determined by near-infrared spectroscopy
Xu et al. Progress on noninvasive and minimally invasive methods on transcutaneous blood glucose sensing

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2005825413

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2007545509

Country of ref document: JP

WWP Wipo information: published in national office

Ref document number: 2005825413

Country of ref document: EP

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)